Xenon Pharmaceuticals Inc
XENE · NASDAQ
Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.
Market Data
Price
$52.40
+0.30 (+0.58%)
Market Cap$5.04B
P/E Ratio—
EPS$—
52W High$63.95
52W Low$30.00
Beta0.66
Data from Finnhub · Updated Jun 16, 2026